📰 Avery Ince News
Avery Ince News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Avery Ince. Real-time updates on events, politics, business and more.
November 14, 2023
Ince describes why patients who are considered fragile are often underdiagnosed and undertreated, and that the VOYAGER PAD analyses can encourage the treatment of the fragile population.
March 5, 2023
TITUSVILLE, NJ,March 5, 2023 - The Janssen Pharmaceutical Companies of Johnson & Johnson today announced data from a new prespecified analysis from the Phase 3 VOYAGER PAD clinical trial... | March 5, 2023
January 13, 2023
This week, our guests are Viktoriya Vasilenko, from Knowledge Gate, and Avery Ince, from Janssen Scientific Affairs.
December 9, 2022
/PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced observational data from eight years of clinical practice showing that...
December 9, 2022
TITUSVILLE, NJ, December 9, 2022 - The Janssen Pharmaceutical Companies of Johnson & Johnson today announced observational data from eight years of clinical practice showing that... | December 9, 2022
October 16, 2022
PAD is a leading cause of amputations in the U.S. But this serious circulatory condition often goes underdiagnosed and undertreated, so millions of Americans—especially in the Black community—don’t know they have it. Janssen’s Save Legs. Change Lives.™ aims to change that.
March 31, 2022
/PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the launch of Save Legs. Change Lives.™ Spot Peripheral Artery...